Altered Immune Profiles in Non‐Failing Heart Donors With Induced Long QT Syndrome: A Potential Risk Factor for Cardiac Allograft Vasculopathy
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Zhi Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Vascular Surgery, People's Hospital of Deyang City, Deyang, Sichuan, P.R. China. Hauptthemen laut MEDLINE: Heart Transplantation, Long QT Syndrome, Tissue Donors, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Cardiac allograft vasculopathy (CAV) develops more aggressively in recipients of hearts from brain‐dead (BD) donors with induced long QT syndrome (iLQTS), yet the underlying mechanisms remain poorly understood. In this study, we employ a multi‐omics and experimental framework to explore the role of neuro‐immune interactions in non‐failing donor hearts affected by iLQTS.
Methods
Single‐nuclei RNA sequencing (snRNA‐seq) compared four iLQTS and four non‐arrhythmic non‐failing donor hearts. Pathway enrichment and cell‐cell communication were assessed. Plasma proteome data from BD donors and neuronal differentially expressed (DE) genes were integrated via Omicsnet. Human BD donor transcriptomes data were analyzed for immune correlation.
Results
ILQTS hearts showed elevated T/mast cells and upregulated leukocyte migration/focal adhesion pathways. Neuronal signaling (NGF, HSPG) and adhesion molecules (ITGB1, LAMININ) drove immune trafficking. Integrative proteomics identified ITGB1 as a central hub linking neuronal DE genes to BD‐associated plasma proteins. Human validation linked activated CD4 + T cells/Th2 enrichment to prolonged QT intervals.
Conclusions
Neuro‐immune dysregulation and integrin signaling related T cell activation underlie iLQTS‐related heart donors. Targeting neuronal‐integrin crosstalk may reduce CAV progression and improve transplant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Vascular Surgery, People's Hospital of Deyang City, Deyang, Sichuan, P.R. China.
- College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
- Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
- Department of Nephrology, People's Hospital of Deyang City, Deyang, Sichuan, P.R. China.
ORCID-Profile: Zhi Wen
Zitieren
APA
Wen, Z., Shao, S., Feng, Y., Wang, Z., Wu, J., Wu, C., & Tian, M. (2025). Altered Immune Profiles in Non‐Failing Heart Donors With Induced Long QT Syndrome: A Potential Risk Factor for Cardiac Allograft Vasculopathy. Clinical Transplantation. https://doi.org/10.1111/ctr.70286
Vancouver
Wen Z, Shao S, Feng Y, Wang Z, Wu J, Wu C, et al. Altered Immune Profiles in Non‐Failing Heart Donors With Induced Long QT Syndrome: A Potential Risk Factor for Cardiac Allograft Vasculopathy. Clinical Transplantation. 2025. doi:10.1111/ctr.70286
BibTeX
@article{Wen2025,
author = {Wen, Zhi and Shao, Shuai and Feng, Yu and Wang, Zheng and Wu, Jianqiang and Wu, Changxue and Tian, Mingwu},
title = {Altered Immune Profiles in Non‐Failing Heart Donors With Induced Long QT Syndrome: A Potential Risk Factor for Cardiac Allograft Vasculopathy},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70286}
}
EUVIMED